Baseline suv and early response, but not mtv, are associated with outcome in relapsed/refractory hodgkin lymphoma patients treated with nivolumab in the checkmate 205 trial
Hematological Oncology（2023）
关键词
nivolumab,relapsed/refractory hodgkin
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要